Jump to content

vaper89

Forumlid
  • Content Count

    331
  • Joined

  • Last visited

  • Days Won

    2

vaper89 last won the day on October 23

vaper89 had the most liked content!

Community Reputation

458 Excellent

About vaper89

  • Rank
    Advanced Member

Profile Information

  • Location
    Drenthe

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. Bron van 14 november: https://www.thesun.co.uk/news/10341501/is-vaping-safe-expert-questions/ CIG OR TWIST Is it safe to vape? As docs urge e-cig ban after Brit teen nearly died, we get an expert to answers all your questions Grant Rollings 13 Nov 2019, 23:15 Updated: 14 Nov 2019, 18:34 WITH a British teenager having suffered a severe allergic reaction to vaping, users fear the alternative to cigarettes could carry hidden dangers. But while a German professor warned that e-cigs might harm the brain, lungs, heart and blood vessels, the extent of the risk remains unclear. Here, British expert Professor PETER HAJEK answers the big questions. 4 The risks of e-cigarettes remain unclear after a teenager suffered a severe allergic reaction to vapingCredit: iStock - Getty ISN’T vaping supposed to be safer than smoking? Yes, vaping is much less dangerous than smoking tobacco. For smokers who switch to vaping, they will remove the risks to their health by a factor of 95 per cent. The risk of cancer, heart disease and lung disease can be expected to be substantially reduced, too. The current estimate is that vaping poses less than five per cent of the risks of smoking cigarettes. CAN vaping kill you? There have been no deaths from vaping nicotine e-cigarettes of the type used in the UK. WHAT about the case of teen Ewan Fisher, from Nottingham, whose lungs were affected by vaping? It looks like this case might have been the result of a rare allergic reaction to one of the ingredients in an e-cigarette. There are 3.6million vapers in the UK and this is the first such case. WHAT about reports of deaths in the United States? The outbreak of lung injury in America is due to contaminants in illegally-produced marijuana/THC cartridges. This has nothing to do with the type of e-cigarettes that are used by smokers in the UK. SHOULD vapers be worried about the report by Prof Thomas Munzel in Mainz, Germany, which claims that vaping can harm the brain, heart, lungs and blood vessels? This report found two things. In humans, nicotine from e-cigarettes produced a typical short-term stimulant effect, also seen after drinking coffee, that on its own signals no danger. In mice and in tissue samples, acrolein – a chemical that can be generated when e-liquid is fried – had more damaging effects. This, however, is not relevant for human vapers. DOES vaping pose no risk? There is likely to be some risk from vaping. But the data we have so far is only from people who have vaped for two or three years and this raised no serious health concerns. IS vaping addictive? Vaping seems to satisfy smokers who are already used to nicotine, but it does not appear to be very appealing or addictive for non-smokers. It is rare for non- smokers to go on to become daily vapers. The Sun says THE hysteria over vaping’s perils is absurd. In an ideal world no one would vape or smoke. But the world isn’t ideal and cigarettes are vastly more dangerous. It would be mad to follow other countries and ban vaping, given its huge ­success in getting smokers to quit. Yes, there are isolated scares and even deaths in the US where the market — unlike ours — is almost unregulated. But smoking kills 20 A DAY in the UK. Vaping saves lives. End the backlash.
  2. De monitor is ook weer bezig met onzin te spuwen.. check hun website maar eens mocht je het willen lezen iets met muizen nicotine en hersenschade.. en de directe vertaling naar mensen wat een wetenschappelijke doodzonde is.
  3. De agenda van sommigen wordt zo langzamerhand wel heel erg opzichtig.. Te gek voor woorden, verwerpelijk en onethisch..
  4. @Pazmaster sowieso het artikel in AD mist alle nuance zoals het feit dat het om een zeer zeldzame allergische reactie ging dat als trigger diende... Die vdToorn tjah.. wartaal is het goede woord..
  5. Voor de liefhebber: https://ash.org.uk/wp-content/uploads/2019/10/PHE-mental-health-trust-2019-survey-full-report_v12.pdf zie het dik gedrukte e-sigaretten onderzoek van ASH oktober 2019. bevindingen van het onderzoek: Key findings and recommendations Highlights The target in the Government’s Tobacco Control Plan was for all mental health trusts to implement comprehensive smokefree policies by 2018. By April 2019, 82% of trusts who responded to the survey had a fully comprehensive smokefree policy in operation. All trusts offered nicotine replacement therapy (NRT) to their patients but only 47% offered the choice of combination NRT or varenicline. The use of e-cigarettes by some or all patients was permitted in 91% of trusts. Significant staff time was spent supporting smoking: staff accompanied patients on smoking breaks every day in 57% of surveyed trusts. Two fifths (42%) of surveyed trusts had experienced conflicts between their own smokefree policy and the policy or practice of neighbouring or host trusts. Methods Findings are from an online survey of mental health trusts in England with an 83% response rate (45 out of 54 trusts responded in full). Smokefree policy implementation Four fifths (82%) of surveyed trusts had a comprehensive smokefree policy in operation prohibiting smoking on wards and hospital grounds*. The remaining fifth (18%) of surveyed trusts still permitted smoking in ward courtyards or in designated areas on the hospital grounds. The most commonly identified enablers of smokefree policy were leadership, staff support, e-cigarettes and training. The most commonly identified barriers to smokefree policy implementation were staff resistance, patient resistance, lack of senior management leadership and insufficient resources. Recommendation 1. Mental health trusts that have yet to implement comprehensive smokefree policies should do so at their earliest opportunity. If additional support is needed, they should seek guidance and support from Public Health England, NHS England and trusts where such policies are established and working well. * In May 2019 initial findings from this survey were provided to PHE and DHSC to track the Tobacco Control Plan ambition (Survey of smokefree implementation in NHS mental health trusts in England). The results were framed toenable comparison with a similar survey of acute trusts which designated trusts as being ‘smokefree or substantially smokefree’ if they scored five or more points on a seven-criteria scale. This analysis found 70% ofmental health trusts to be ‘smokefree or substantially smokefree’ compared to 63% of acute trusts. The corefinding in the fuller analysis presented here is that 82% of mental health trusts have a comprehensive smokefree policy in operation. This is a single indicator, not a compound measure, and unlike the earlier report does not include survey non-responders in the baseline 3 Smokefree sites in practice Noncompliance with smokefree policy was universal: all surveyed trusts reported smoking on site though this was much less frequent in some trusts than in others. In trusts with comprehensive smokefree policies in operation: patients were found smoking in their bedrooms or bathrooms at least every week in 48% of trusts patients were found smoking in ward courtyards every day in 22% of trusts staff accompanied patients on smoking breaks every day in 57% of trusts Section 17 leave was used to facilitate smoking breaks in 86% of trusts Problems arose at trust boundaries: all but one of the surveyed trusts reported problems with cigarette littering on their boundaries 42% of surveyed trusts had experienced conflicts between their own smokefree policy and the policy or practice of neighbouring or host trusts Recommendations Mental health trust managers and smokefree leads should work with ward managers and staff to audit and reduce the time spent by staff escorting patients on smoking breaks. Trusts should ensure that Section 17 leave is not improperly used to facilitate smoking. NHS acute trusts that host mental health trusts on their grounds should work with them to ensure that comprehensive smokefree policies are consistently implemented across all NHS premises, including at trust boundaries. Treatment for tobacco dependence Most but not all of the surveyed trusts (93%) provided on-site support for tobacco dependence: 84% of trusts had trained frontline staff 44% of trusts employed dedicated smoking cessation workers 29% of trusts had a dedicated smoking cessation service All trusts offered nicotine replacement therapy (NRT) to their patients but only 47% offered the choice of combination NRT or varenicline. In 55% of trusts, patients were not always asked their smoking status on admission. In 51% of trusts, local authority funded community stop smoking services were not available to people with mental health conditions on discharge in some or all of the local authorities covered by the trust. Three fifths of trusts (62%) have made some investment of their own in community stop smoking support. Recommendations Smoking status should be routinely and consistently asked and recorded on patients’ admission toacute mental health services. Effective treatment and support for tobacco dependence should be made available to inpatients from the point of admission onwards. As a minimum, all trusts should ensure that staff who have had at least two days of face-to-face training in smoking cessation are available to support smokers throughout their stay. Trusts should offer both combination NRT and varenicline to inpatient smokers, with behavioural support, to give them the best possible chance of quitting. 4 9. Local authorities should work with mental health trusts to ensure that people with mental health conditions in the community can access appropriate specialist support to enable them to quit smoking or successfully abstain when necessary. E-cigarettes In 91% of surveyed trusts, some or all inpatients were permitted to use e-cigarettes. 47% of surveyed trusts allowed all types of e-cigarettes to be used 31% of surveyed trusts only allowed the use of non-rechargeable, disposable devices All but one trust restricted where e-cigarettes could be used. 44% of surveyed trusts allowed the use of e-cigarettes indoors three quarters (76%) of surveyed trusts allowed the use of e-cigarettes in ward courtyards Two fifths (42%) of surveyed trusts provided e-cigarettes free to their patients. Recommendations 10. Mental health trusts should consider how best to utilise e-cigarettes in acute settings to reduce the harm of smoking. 11. Where e-cigarettes are not available on site, trusts should consider taking steps to make them available.
  6. Collega van die longarts en niemand minder dan Linda Bauld met een reactie 🙂
  7. Publicatie dinsdag 29 oktober 2019 https://publichealthmatters.blog.gov.uk/2019/10/29/vaping-and-lung-disease-in-the-us-phes-advice/ het artikel: Vaping and lung disease in the US: PHE’s advice Posted by: John Newton, Posted on: 29 October 2019 - Categories: Health Improvement What’s happening in the US? Since mid-September, headlines around the world have warned about an outbreak of serious lung disease across the US, said to be associated with vaping. As of October 22, 1,604 cases have been reported to the Center for Disease Control (CDC) from 49 US states, including 34 deaths. The US has an estimated 9 million e-cigarette users in the country, but weekly updates on the CDC website make it clear that the group of people affected is very specific. The outbreak appears to be largely among young men: 70% of patients are male and the average age is 24. Almost half (46%) are under 21. Dr Dana Meaney-Delman, head of the CDC team investigating the outbreak has reported that “We've narrowed this clearly to THC-containing products that are associated with most patients who are experiencing lung injury. The specific substance or substances we have not identified yet”. THC is the main psychoactive component of cannabis and the CDC has said that the products identified are being obtained off the street or from other informal sources (e.g. friends, family members or illicit dealers). The specific chemical or chemicals that are causing the illness and deaths have not yet been identified and it is not clear that all cases are the same kind of injury. The outbreak does not appear to be associated with long term use of nicotine e-cigarettes, which have been used in the US for over 10 years. The first case was reported at the end of March this year and along with all the other cases appears to be linked with very recent use causing a rapid harmful effect. Because of what’s happened, several US states have banned the use of flavourings in e-cigarettes and have called for urgent action. Our concern is that the responses we have seen to the problem in the US and in other countries may increase the already widespread misunderstanding about the relative safety of nicotine e-cigarettes, deterring smokers from switching and risk driving vapers who have switched back to smoking. There is a real risk therefore that such a reaction will mean people continue to smoke, which will undoubtedly put lives at risk. Could it happen here? We need to be clear about what this outbreak is and is not. It is not a problem linked to long-term use of regulated nicotine vaping products. If it were, we would expect to see a very different demographic profile affected, more typical of long term vapers. E-cigarettes containing nicotine are more tightly regulated in the UK than in the US and our medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for overseeing the tobacco regulations. The main chemicals under suspicion in the US such as THC and Vitamin E acetate oil are not permitted in e-cigarettes in this country. The MHRA operates the Yellow Card Scheme, where healthcare workers and members of the public can notify any health problems. Healthcare workers and the public can report a side effect or safety concern for e-cigarettes on the Yellow Card Scheme. It’s also a similar situation across Europe, where there are similar restrictions on e-cigarettes as in the UK – under the European Tobacco Products Directive. No vaping related cases like in the US have been reported to the EMCDDA by its EU Early Warning System Network to date. The illicit drugs market is global and it is possible that similar products to those in the US are available in the UK, which is why we are warning of this new and serious threat and continue to monitor carefully the situation in the UK. PHE’s advice on e-cigarettes remains the same PHE has not changed its advice on nicotine containing e-cigarettes: Smokers should consider switching completely and vapers should stop smoking. We are as certain as ever that e-cigarettes are far less harmful than smoking, which kills almost 220 people in England every day. The evidence still shows that vaping carries a small fraction of the risk of smoking. Using a nicotine-containing e-cigarette makes it much more likely someone will quit successfully than relying on willpower alone. But it’s important to use regulated e-liquids and never risk vaping home-made or illicit e-liquids or adding substances. Vaping devices that do not include nicotine come under a different set of regulations, the General Product Safety Regulations. These are generally less stringent than the regulations covering nicotine containing e-cigarettes. We are monitoring the situation We are keen to understand more about what is happening in the US, so we’re in regular contact with US federal agencies including the CDC, the Food and Drug Administration (FDA) and the National Institute on Drug Abuse (NIDA). We are also working closely with our expert advisors on respiratory health and the MHRA. The National Poisons Information Service records and analyses reports of poisoning. The rate of poisonings from e-cigarettes has remained stable. Cases of moderate or severe toxicity remain rare and associated with accidental and occasionally deliberate misuse and not with inhalation of nicotine. We’re also continually updating the evidence on e-cigarettes. The government’s Tobacco Control Plan for England requires PHE to update its 2015 review of e-cigarettes and other novel nicotine delivery systems every year until the end of the current Parliament in 2022. We are currently in the process of producing these reviews. The most recent one was published in February and focused on vaping prevalence and characteristics of e-cigarette use in adults and young people, and e-cigarette use in English stop-smoking services. The next review is due to be published in early 2020 and will include the latest analysis of use among young people. We have updated our advice to the public, including on our FRANK website. We have not issued an alert to date. The evidence on the causes of the deaths in the US is not yet conclusive, the information has not reached the threshold to issue an alert and we continue to keep the issue under close review. We have also cascaded information about nicotine-inhaling products to relevant local services, including local public health teams, stop smoking services and substance misuse services. This directs people to report any adverse effects to the MHRA’s Yellow Card Scheme.
  8. Nog meer media melden het: https://www.washingtonpost.com/health/2019/10/25/cdc-most-people-who-died-vaping-linked-disease-used-products-containing-thc/
  9. https://www.hln.be/nieuws/buitenland/-meeste-slachtoffers-van-mysterieuze-vape-ziekte-gebruikten-vloeistoffen-met-cannabis~a756d3d8/ Enkel de sluitende zin slaat de plank een beetje mis. Inleiding: De Amerikaanse gezondheidsautoriteiten zijn er meer en meer van overtuigd dat producten met THC, het psychoactieve middel van cannabis, een rol hebben gespeeld bij meerdere overlijdens die terug te voeren zijn op ‘vapen’. Gezondheidsdienst CDC (Centers for Disease Control and Prevention) meldde eerder nu al 34 sterfgevallen geregistreerd te hebben die terug te voeren zijn op het gebruik van e-sigaretten. De dienst verzamelde informatie over de uitbraak van een mysterieuze longziekte in 49 van de 50 Amerikaanse staten en maakte bekend dat er in het hele land 1.604 getroffen patiënten zijn. Vorsers onderzochten van deze groep de medische gegevens van 860 gevallen. 85% van deze vapers gaf aan producten te hebben gebruikt die THC bevatten - gekocht op de zwarte markt -, terwijl 10% louter bij nicotinegerelateerde middelen bleef.
  10. https://regulatorwatch.com/brent_stafford/scientist-says-vaping-is-shown-safe-lung-hysteria-is-misleading/ publicatie 21 oktober 2019
  11. Aspire is wel een goed merk :) Waar twijfel je tussen dan of aan? @melliemvdg
  12. https://www.businessinsider.com.au/nicotine-patch-creator-anti-vaping-forces-overhyping-danger-2019-10 publicatie 23 oktober 2019
×
×
  • Create New...